Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Hepatitis C virus manipulates humans as its favorite host for long term relationship.

Ray RB, Ray R.

Hepatology. 2018 Aug 13. doi: 10.1002/hep.30214. [Epub ahead of print] Review.

PMID:
30102776
2.

Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion.

Sur S, Sasaki R, Devhare P, Steele R, Ray R, Ray RB.

J Virol. 2018 Aug 8. pii: JVI.01215-18. doi: 10.1128/JVI.01215-18. [Epub ahead of print]

PMID:
30089699
3.

Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.

Shim SH, Sur S, Steele R, Albert CJ, Huang C, Ford DA, Ray RB.

Mol Carcinog. 2018 Aug 3. doi: 10.1002/mc.22882. [Epub ahead of print]

PMID:
30074275
4.

Author Correction: N-terminal gelsolin fragment potentiates TRAIL mediated death in resistant hepatoma cells.

Meyer K, Kwon YC, Ray RB, Ray R.

Sci Rep. 2018 Apr 24;8(1):6696. doi: 10.1038/s41598-018-24095-7.

5.

Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.

Devhare PB, Ray RB.

Mol Aspects Med. 2018 Apr;60:115-122. doi: 10.1016/j.mam.2017.11.001. Epub 2017 Nov 11. Review.

PMID:
29122679
6.

Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.

Sur S, Steele R, Aurora R, Varvares M, Schwetye KE, Ray RB.

Cancer Prev Res (Phila). 2018 Apr;11(4):191-202. doi: 10.1158/1940-6207.CAPR-17-0237. Epub 2017 Oct 23.

PMID:
29061560
7.

Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death.

Muhammad N, Steele R, Isbell TS, Philips N, Ray RB.

Oncotarget. 2017 Aug 3;8(39):66226-66236. doi: 10.18632/oncotarget.19887. eCollection 2017 Sep 12.

8.

Zika virus infection dysregulates human neural stem cell growth and inhibits differentiation into neuroprogenitor cells.

Devhare P, Meyer K, Steele R, Ray RB, Ray R.

Cell Death Dis. 2017 Oct 12;8(10):e3106. doi: 10.1038/cddis.2017.517.

9.

N-terminal gelsolin fragment potentiates TRAIL mediated death in resistant hepatoma cells.

Meyer K, Kwon YC, Ray RB, Ray R.

Sci Rep. 2017 Oct 9;7(1):12803. doi: 10.1038/s41598-017-13131-7. Erratum in: Sci Rep. 2018 Apr 24;8(1):6696.

10.

Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.

Sasaki R, Devhare P, Ray RB, Ray R.

Hepatology. 2017 Dec;66(6):1766-1778. doi: 10.1002/hep.29346. Epub 2017 Oct 30.

PMID:
28664988
11.

Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.

Bhattacharya S, Muhammad N, Steele R, Kornbluth J, Ray RB.

Cancer Prev Res (Phila). 2017 Jun;10(6):337-344. doi: 10.1158/1940-6207.CAPR-17-0046. Epub 2017 May 2.

12.

Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".

Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB.

J Virol. 2017 Apr 28;91(10). pii: e00349-17. doi: 10.1128/JVI.00349-17. Print 2017 May 15. No abstract available.

13.

Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells.

Sasaki R, Devhare PB, Steele R, Ray R, Ray RB.

Hepatology. 2017 Sep;66(3):746-757. doi: 10.1002/hep.29170. Epub 2017 Jul 18.

PMID:
28318046
14.

A novel role of exosomes in the vaccination approach.

Devhare PB, Ray RB.

Ann Transl Med. 2017 Jan;5(1):23. doi: 10.21037/atm.2016.12.75. No abstract available.

15.

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.

Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB.

J Virol. 2017 Feb 28;91(6). pii: e02225-16. doi: 10.1128/JVI.02225-16. Print 2017 Mar 15. Erratum in: J Virol. 2017 Apr 28;91(10 ):.

16.

Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.

Muhammad N, Bhattacharya S, Steele R, Phillips N, Ray RB.

Clin Cancer Res. 2017 Jun 15;23(12):3120-3128. doi: 10.1158/1078-0432.CCR-16-2811. Epub 2016 Dec 13.

17.

Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities.

Devhare PB, Steele R, Di Bisceglie AM, Kaplan DE, Ray RB.

Gene Expr. 2017 Feb 10;17(2):89-98. doi: 10.3727/105221616X693594. Epub 2016 Oct 19.

PMID:
27765085
18.

Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.

Muhammad N, Bhattacharya S, Steele R, Ray RB.

Oncotarget. 2016 Sep 6;7(36):58595-58605. doi: 10.18632/oncotarget.11193. Review.

19.

Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.

Bhattacharya S, Muhammad N, Steele R, Peng G, Ray RB.

Oncotarget. 2016 May 31;7(22):33202-9. doi: 10.18632/oncotarget.8898.

20.

Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.

Bhattacharya S, Steele R, Shrivastava S, Chakraborty S, Di Bisceglie AM, Ray RB.

Am J Pathol. 2016 Feb;186(2):242-7. doi: 10.1016/j.ajpath.2015.10.003.

21.

Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway.

Shrivastava S, Devhare P, Sujijantarat N, Steele R, Kwon YC, Ray R, Ray RB.

J Virol. 2015 Nov 18;90(3):1387-96. doi: 10.1128/JVI.02383-15. Print 2016 Feb 1.

22.

Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.

Kwon YC, Bose SK, Steele R, Meyer K, Di Bisceglie AM, Ray RB, Ray R.

J Virol. 2015 Nov;89(22):11549-56. doi: 10.1128/JVI.01946-15. Epub 2015 Sep 9.

23.

MicroRNAs: Role in Hepatitis C Virus pathogenesis.

Shrivastava S, Steele R, Ray R, Ray RB.

Genes Dis. 2015 Mar 1;2(1):35-45.

24.

Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.

Meyer K, Kwon YC, Liu S, Hagedorn CH, Ray RB, Ray R.

Sci Rep. 2015 Mar 11;5:9012. doi: 10.1038/srep09012.

25.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

26.

Identification of molecular signature of head and neck cancer stem-like cells.

Shrivastava S, Steele R, Sowadski M, Crawford SE, Varvares M, Ray RB.

Sci Rep. 2015 Jan 15;5:7819. doi: 10.1038/srep07819.

27.

Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.

Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB.

J Virol. 2014 Jul;88(14):7929-40. doi: 10.1128/JVI.00787-14. Epub 2014 Apr 30.

28.

Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Kwon YC, Ray RB, Ray R.

EXCLI J. 2014 Aug 27;13:977-96. eCollection 2014. Review.

29.

Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.

Rajamoorthi A, Shrivastava S, Steele R, Nerurkar P, Gonzalez JG, Crawford S, Varvares M, Ray RB.

PLoS One. 2013 Oct 17;8(10):e78006. doi: 10.1371/journal.pone.0078006. eCollection 2013.

30.

Hepatitis C virus infection, microRNA and liver disease progression.

Shrivastava S, Mukherjee A, Ray RB.

World J Hepatol. 2013 Sep 27;5(9):479-86. doi: 10.4254/wjh.v5.i9.479. Review.

31.

Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.

Shrivastava S, Mukherjee A, Ray R, Ray RB.

J Virol. 2013 Nov;87(22):12284-90. doi: 10.1128/JVI.01962-13. Epub 2013 Sep 4.

32.

Hepatitis C virus NS5A protein modulates IRF-7-mediated interferon-α signaling.

Chowdhury JB, Kim H, Ray R, Ray RB.

J Interferon Cytokine Res. 2014 Jan;34(1):16-21. doi: 10.1089/jir.2013.0038. Epub 2013 Aug 20.

33.

Functions of autophagy in normal and diseased liver.

Czaja MJ, Ding WX, Donohue TM Jr, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, Perlmutter DH, Randall G, Ray RB, Tsung A, Yin XM.

Autophagy. 2013 Aug;9(8):1131-58. doi: 10.4161/auto.25063. Epub 2013 May 22. Review.

34.

Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Diamond MS, Atkinson JP, Ray R.

J Virol. 2013 Jul;87(14):7902-10. doi: 10.1128/JVI.00917-13. Epub 2013 May 8.

35.

Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.

Bittar C, Shrivastava S, Bhanja Chowdhury J, Rahal P, Ray RB.

PLoS One. 2013 Apr 30;8(4):e62581. doi: 10.1371/journal.pone.0062581. Print 2013.

36.

Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.

Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB.

Hepatology. 2013 Sep;58(3):863-71. doi: 10.1002/hep.26296. Epub 2013 Jul 23.

37.

Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R.

J Virol. 2012 Dec;86(24):13621-8. doi: 10.1128/JVI.02016-12. Epub 2012 Oct 3.

38.

Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.

Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB.

J Virol. 2012 Sep;86(18):10221-5. doi: 10.1128/JVI.00882-12. Epub 2012 Jul 11.

39.

Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling.

Shrivastava S, Bhanja Chowdhury J, Steele R, Ray R, Ray RB.

J Virol. 2012 Aug;86(16):8705-12. doi: 10.1128/JVI.00616-12. Epub 2012 Jun 6.

40.

Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance.

Bose SK, Shrivastava S, Meyer K, Ray RB, Ray R.

J Virol. 2012 Jun;86(11):6315-22. doi: 10.1128/JVI.00050-12. Epub 2012 Mar 28.

41.

miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.

Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB.

Mol Cancer Ther. 2012 May;11(5):1166-73. doi: 10.1158/1535-7163.MCT-12-0100. Epub 2012 Mar 8.

42.

Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.

Ru P, Steele R, Hsueh EC, Ray RB.

Genes Cancer. 2011 Jul;2(7):720-7. doi: 10.1177/1947601911425832.

43.

Hepatitis C virus proteins inhibit C3 complement production.

Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Ray R.

J Virol. 2012 Feb;86(4):2221-8. doi: 10.1128/JVI.06577-11. Epub 2011 Dec 14.

44.

Oncogenic potential of hepatitis C virus proteins.

Banerjee A, Ray RB, Ray R.

Viruses. 2010 Sep;2(9):2108-33. doi: 10.3390/v2092108. Epub 2010 Sep 27.

45.

ISG56 and IFITM1 proteins inhibit hepatitis C virus replication.

Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB.

J Virol. 2011 Dec;85(24):12881-9. doi: 10.1128/JVI.05633-11. Epub 2011 Oct 5.

46.

Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.

Ru P, Steele R, Nerurkar PV, Phillips N, Ray RB.

Cancer Prev Res (Phila). 2011 Dec;4(12):2122-30. doi: 10.1158/1940-6207.CAPR-11-0376. Epub 2011 Sep 12.

47.

Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer.

Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray RB, Chang C, Yokosuka O.

Genes Cancer. 2010 Aug;1(8):859-67. doi: 10.1177/1947601910383417.

48.

Transcriptional repression of C4 complement by hepatitis C virus proteins.

Banerjee A, Mazumdar B, Meyer K, Di Bisceglie AM, Ray RB, Ray R.

J Virol. 2011 May;85(9):4157-66. doi: 10.1128/JVI.02449-10. Epub 2011 Feb 23.

49.

Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.

Shrivastava S, Raychoudhuri A, Steele R, Ray R, Ray RB.

Hepatology. 2011 Feb;53(2):406-14. doi: 10.1002/hep.24073. Epub 2011 Jan 10.

50.

Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes.

Raychoudhuri A, Shrivastava S, Steele R, Dash S, Kanda T, Ray R, Ray RB.

J Virol. 2010 Nov;84(21):10991-8. doi: 10.1128/JVI.00900-10. Epub 2010 Sep 1.

Supplemental Content

Support Center